These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6150119)

  • 1. The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.
    Toffano G; Savoini G; Aporti F; Calzolari S; Consolazione A; Maura G; Marchi M; Raiteri M; Agnati LF
    J Neurosci Res; 1984; 12(2-3):397-408. PubMed ID: 6150119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of tubulin gene expression and increase in oligo(dT)-bound RNA in the rat brain after nigrostriatal pathway unilateral lesion and treatment with ganglioside.
    Yavin E; Gil S; Consolazione A; dal Toso R; Leon A
    J Neurosci Res; 1987; 18(4):615-20. PubMed ID: 3437475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons.
    Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M
    Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
    Schneider JS; Kean A; DiStefano L
    J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic GM1 ganglioside treatment reduces dopamine cell body degeneration in the substantia nigra after unilateral hemitransection in rat.
    Toffano G; Savoini GE; Moroni F; Lombardi G; Calzà L; Agnati LF
    Brain Res; 1984 Apr; 296(2):233-9. PubMed ID: 6142756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
    Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
    Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion.
    Raiteri M; Versace P; Marchi M
    Eur J Pharmacol; 1985 Dec; 118(3):347-50. PubMed ID: 4085560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats.
    Goettl VM; Wemlinger TA; Duchemin AM; Neff NH; Hadjiconstantinou M
    Neuroscience; 1999; 92(3):991-1000. PubMed ID: 10426539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides.
    Agnati LF; Fuxe K; Zini I; Davalli P; Corti A; Calza L; Toffano G; Zoli M; Piccinini G; Goldstein M
    Acta Physiol Scand; 1985 Aug; 124(4):499-506. PubMed ID: 2864781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A; Tinker JP; Schneider JS
    Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of GM1 ganglioside treatment on postlesion responses of cholinergic enzymes in rat hippocampus after various partial deafferentations.
    Oderfeld-Nowak B; Skup M; Ułas J; Jezierska M; Gradkowska M; Zaremba M
    J Neurosci Res; 1984; 12(2-3):409-20. PubMed ID: 6502758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
    Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M
    Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
    Janson AM; Fuxe K
    Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gangliosides on the functional recovery of damaged brain.
    Toffano G; Savoini G; Aldinio C; Valenti G; Dal Toso R; Leon A; Calza L; Zini I; Agnati LF; Fuxe K
    Adv Exp Med Biol; 1984; 174():475-88. PubMed ID: 6741741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor and the monosialoganglioside GM1: analogous and different in vivo effects on biochemical, morphological, and behavioral parameters of adult cortically lesioned rats.
    Garofalo L; Cuello AC
    Exp Neurol; 1994 Feb; 125(2):195-217. PubMed ID: 8313938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.